THRM vs DORM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DORM Captures Institutional Edge (2โ2 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dorman Products, Inc. New (DORM) driven by superior Growth & Margin, Momentum & Technical while THRM counters with relative strength in Valuation, Options & Structure. Fundamentally, THRM trades at 9.4x Forward P/E with 7.1% operating margin (+4.7% YoY revenue) versus DORM at 14.6x Forward P/E and 15.6% operating margin (+3.3% YoY). In options structure, THRM sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against DORM sits in CONSOLIDATION (26th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | THRM Revenue | DORM Revenue | THRM Op. Margin | DORM Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $1.05B | $970M | 6.9% | 17.6% | DORM |
| FY2019 | $970M | $990M | 8.7% | 10.7% | DORM |
| FY2020 | $910M | $1.09B | 9.8% | 12.2% | DORM |
| FY2021 | $1.05B | $1.35B | 11.0% | 12.8% | DORM |
| FY2022 | $1.20B | $1.73B | 4.0% | 9.9% | DORM |
| FY2023 | $1.47B | $1.93B | 5.3% | 11.1% | DORM |
| FY2024 | $1.46B | $2.01B | 7.3% | 14.6% | DORM |
| FY2025 | $1.50B | $2.13B | 5.5% | 14.1% | DORM |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | THRM | DORM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | $3.9B | Larger Scale | DORM |
| Trailing P/E Ratio Valuation | 103.9x | 19.7x | Lower Multiple | DORM |
| Forward P/E Ratio Valuation | 9.4x | 14.6x | Lower Multiple | THRM |
| Revenue Growth (YoY) Growth | +4.7% | +3.3% | Higher Growth | THRM |
| Operating Margin (TTM) Profitability | 7.1% | 15.6% | Higher Margin | DORM |
| Net Profit Margin Profitability | 0.6% | 9.3% | Higher Margin | DORM |
| Return on Equity (ROE) Capital Efficiency | 1.3% | 13.3% | Higher ROE | DORM |
| 52-Week Range Position Momentum | 14% ($25โ$48) | 59% ($98โ$155) | Stronger Trend | DORM |
| Beta / 30D Volatility Risk Regime | 0.99ฮฒ ยท 72% Vol | 0.70ฮฒ ยท 34% Vol | Lower Realized Risk | DORM |
| Unified Institutional Score Composite Signal | 35.4 / 100 (SELL) | 36.0 / 100 (SELL) | Higher Composite | DORM |